Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

151.33 +1.72 (+1.15%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,051,168
Open 149.67
Bid (Size) 151.00 (12)
Ask (Size) 151.10 (5)
Prev. Close 149.61
Today's Range 149.22 - 151.50
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Magnificent Stocks That Are Passive Income Machines
Via The Motley Fool
US-China Trade Truce, Trump's Middle East Deals Spark Wall Street Rally: This Week In Markets
U.S. and China cut tariffs by 115 points, sparking a stock rally and improving trade outlook. Trump secures $2 trillion in Gulf deals. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff

Performance

YTD
+5.1%
+5.1%
1 Month
-1.7%
-1.7%
3 Month
-3.1%
-3.1%
6 Month
-1.7%
-1.7%
1 Year
-1.9%
-1.9%

More News

Read More
Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails
From Nachawati Law Group
Via Business Wire
Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025
Via Benzinga
Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets
Via Benzinga
Topics Bonds
Exposures Debt Markets
Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Via Benzinga
CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
Via Benzinga
The Smartest Dividend Stocks to Buy With $5,000 Right Now
Via The Motley Fool
Topics Economy Retirement
Exposures Pension Supply Chain
Trump Unveils 'Historic And Transformative' $600 Billion Saudi Deal, Predicts Markets Will 'Go A Lot Higher'
Via Benzinga
Topics Government
Exposures Political
13 Analysts Have This To Say About Johnson & Johnson
Via Benzinga
Peering Into Johnson & Johnson's Recent Short Interest
Via Benzinga
Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
Top S&P500 movers in Monday's pre-market session
Via Chartmill
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform
Via Investor's Business Daily
Topics Government Stocks
Exposures Political US Equities
Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims'
Via Benzinga
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
Via Benzinga
Topics Government
Exposures Political
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Via Benzinga
Topics Government
Exposures Political
Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study
Via Benzinga
Johnson & Johnson’s Psoriasis Drug Meets Goal In Late Stage Study: Retail Yet To Be Impressed
Via Stocktwits
Mattel Appoints Kenvue CFO Paul Ruh As Finance Chief As Toy Maker Navigates Tariff Challenges
Via Stocktwits
Topics Economy Government World Trade
Exposures Political Supply Chain Tariff
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
Via Benzinga
Topics ETFs Government
Exposures Political
Johnson & Johnson expands efforts to champion the nursing workforce globally
From Johnson & Johnson
Via Business Wire
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Via Benzinga

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 151.33
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 05/16/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 397.80B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 398B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.